| Dr Eugene Rudd, | |
|
125 Ashewood Dr, Bristol, TN 37620-5939 | |
| (423) 534-2242 | |
| Not Available |
| Full Name | Dr Eugene Rudd |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Gynecology |
| Location | 125 Ashewood Dr, Bristol, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972928604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | MD 28716 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eugene Rudd, 125 Ashewood Dr, Bristol, TN 37620-5939 Ph: (423) 534-2242 | Dr Eugene Rudd, 125 Ashewood Dr, Bristol, TN 37620-5939 Ph: (423) 534-2242 |
News Archive
New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.
NPR reports on the immediate effects of the proposed health care bill, and that Congressional Democrats are focusing on those benefits in messages to constituents. "The White House is trying to shift the conversation away from the messy legislative process — which Republicans are keying on — and instead focus on what the health care overhaul would do for families and businesses."
Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pursuing the vast number of disease targets in cancer and other illnesses that have eluded traditional small-molecule compounds and are considered "undruggable."
Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the October 3 issue of JAMA.
On May 20, 2009, the US District Court for the District of New Jersey granted the request of AstraZeneca for an injunction barring Apotex (Apotex, Inc. and Apotex Corp.) from launching a generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) in the US. No trial date for the patent litigation has been set.
› Verified 5 days ago
Dr. Samantha Jo Herriott, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 320 Bristol West Blvd, Ste 2c, Bristol, TN 37620 Phone: 423-844-1399 Fax: 423-877-1397 | |
David W. Marden, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd Ste 305e, Bristol, TN 37620 Phone: 423-844-5640 Fax: 423-844-5645 | |
Dr. Gary C Boyle, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2901 W State St, Bristol, TN 37620 Phone: 423-968-2182 Fax: 423-968-7589 | |
Dr. Jeffrey Mcqueary, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd Ste 2700, Bristol, TN 37620 Phone: 423-990-2450 | |
Dr. Wesley F Adams Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2901 W State St, Bristol, TN 37620 Phone: 423-968-2182 Fax: 423-968-7589 | |
Alan L. Gorrell, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 249 Midway Medical Park, Suite 202, Bristol, TN 37620 Phone: 423-844-6220 | |
Dr. Dennis Samuel Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 350 Steeles Rd, Bristol, TN 37620 Phone: 423-844-4925 Fax: 423-844-4933 |